The BILAG multi-centre open randomized controlled trial comparing ciclosporin vs azathioprine in patients with severe SLE [corrected] [published erratum appears in RHEUMATOLOGY 2011 Mar;50(3):634].

MLA

Griffiths B, et al. “The BILAG Multi-Centre Open Randomized Controlled Trial Comparing Ciclosporin vs Azathioprine in Patients with Severe SLE [Corrected] [Published Erratum Appears in RHEUMATOLOGY 2011 Mar;50(3):634].” Rheumatology, vol. 49, no. 4, Apr. 2010, pp. 723–32. EBSCOhost, https://doi.org/10.1093/rheumatology/kep396.

APA

Griffiths B, Emery P, Ryan V, Isenberg D, Akil M, Thompson R, Maddison P, Griffiths ID, Lorenzi A, Miles S, Situnayake D, Teh LS, Plant M, Hallengren C, Nived O, Sturfelt G, Chakravarty K, Tait T, & Gordon C. (2010). The BILAG multi-centre open randomized controlled trial comparing ciclosporin vs azathioprine in patients with severe SLE [corrected] [published erratum appears in RHEUMATOLOGY 2011 Mar;50(3):634]. Rheumatology, 49(4), 723–732. https://doi.org/10.1093/rheumatology/kep396

Chicago

Griffiths B, Emery P, Ryan V, Isenberg D, Akil M, Thompson R, Maddison P, et al. 2010. “The BILAG Multi-Centre Open Randomized Controlled Trial Comparing Ciclosporin vs Azathioprine in Patients with Severe SLE [Corrected] [Published Erratum Appears in RHEUMATOLOGY 2011 Mar;50(3):634].” Rheumatology 49 (4): 723–32. doi:10.1093/rheumatology/kep396.